The Change in Temporal Muscle Thickness in Stroke Patients
1 other identifier
observational
150
1 country
1
Brief Summary
This study aims to evaluate the relationship between sarcopenia and functional outcomes with temporal muscle mass change.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2022
CompletedFirst Posted
Study publicly available on registry
July 13, 2022
CompletedStudy Start
First participant enrolled
July 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedSeptember 5, 2023
January 1, 2023
1.6 years
July 11, 2022
September 1, 2023
Conditions
Outcome Measures
Primary Outcomes (14)
Functional Ambulation Scale
This scale consists of six levels of function, ranging from 0 ( non-ambulatory ) to 5 (independently ambulatory).
Baseline
Functional Ambulation Scale
This scale consists of six levels of function, ranging from 0 ( non-ambulatory ) to 5 (independently ambulatory).
6. month
The Functional Independence Measure (FIM)
FIM is a scale that assesses 18 activities, including self-care, sphincter control, transfer, movement, communication, and social awareness. Total scores range from 18 to 126 (dependent in all domains - independent in all domains).
Baseline
The Functional Independence Measure (FIM)
FIM is a scale that assesses 18 activities, including self-care, sphincter control, transfer, movement, communication, and social awareness. Total scores range from 18 to 126 (dependent in all domains - independent in all domains).
6.month
Modified Rankin Scale (mRS)
It categorizes poststroke disability into six levels ranging from 0 to 5, with absence of symptoms rated as 0 and severe disability or bedriddenness rated as 5. An mRS score of 2 or less was defined as a good outcome, and an mRS score above 2 was defined as a poor outcome.
Baseline
Modified Rankin Scale (mRS)
It categorizes poststroke disability into six levels ranging from 0 to 5, with absence of symptoms rated as 0 and severe disability or bedriddenness rated as 5. An mRS score of 2 or less was defined as a good outcome, and an mRS score above 2 was defined as a poor outcome.
6. month
Handgrip strength
With the JAMAR Hand Dynamometer, 3 measurements will be taken for both hands 60 seconds apart in the standard position and the highest reading will be recorded.
Baseline
Handgrip strength
With the JAMAR Hand Dynamometer, 3 measurements will be taken for both hands 60 seconds apart in the standard position and the highest reading will be recorded.
6. month
Dual energy X-ray absorptiometry (DEXA)
DEXA can be used to determine lean body mass and total body fat. The appendicular skeletal mass index will be used in the evaluation of sarcopenia and in other analyzes.
Baseline
Dual energy X-ray absorptiometry (DEXA)
DEXA can be used to determine lean body mass and total body fat. The appendicular skeletal mass index will be used in the evaluation of sarcopenia and in other analyzes.
6.month
Bioelectrical impedance analysis (BIA)
Body water mass, total body fat, and muscle mass can be determined with BIA.The appendicular skeletal mass index will be used in the evaluation of sarcopenia and in other analyzes.
Baseline
Bioelectrical impedance analysis (BIA)
Body water mass, total body fat, and muscle mass can be determined with BIA.The appendicular skeletal mass index will be used in the evaluation of sarcopenia and in other analyzes.
6.month
Functional Oral Intake Scale
The scale is rated with values between 1 and 7. Level 1-3 refers to tube-dependent feeding, level 4-6 to full oral feeding with restrictions, and level 7 to oral feeding without restrictions.
Baseline
Functional Oral Intake Scale
The scale is rated with values between 1 and 7. Level 1-3 refers to tube-dependent feeding, level 4-6 to full oral feeding with restrictions, and level 7 to oral feeding without restrictions.
6. month
Eligibility Criteria
A tertiary health care facility
You may qualify if:
- Diagnosis of stroke
- Presence of cranial MRI/CT in hospital records
You may not qualify if:
- Medically unstable condition (presence or high risk of impaired consciousness, respiration, or circulation).
- Severe cognitive impairment
- Patients who require intensive care unit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir Bozyaka Research and Training Hostpital
Izmir, Turkey (Türkiye)
Related Publications (3)
Ryan AS, Ivey FM, Serra MC, Hartstein J, Hafer-Macko CE. Sarcopenia and Physical Function in Middle-Aged and Older Stroke Survivors. Arch Phys Med Rehabil. 2017 Mar;98(3):495-499. doi: 10.1016/j.apmr.2016.07.015. Epub 2016 Aug 13.
PMID: 27530769BACKGROUNDNozoe M, Kanai M, Kubo H, Yamamoto M, Shimada S, Mase K. Prestroke sarcopenia and functional outcomes in elderly patients who have had an acute stroke: A prospective cohort study. Nutrition. 2019 Oct;66:44-47. doi: 10.1016/j.nut.2019.04.011. Epub 2019 Apr 25.
PMID: 31207438BACKGROUNDNakanishi N, Okura K, Okamura M, Nawata K, Shinohara A, Tanaka K, Katayama S. Measuring and Monitoring Skeletal Muscle Mass after Stroke: A Review of Current Methods and Clinical Applications. J Stroke Cerebrovasc Dis. 2021 Jun;30(6):105736. doi: 10.1016/j.jstrokecerebrovasdis.2021.105736. Epub 2021 Mar 20.
PMID: 33756264BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bugra Ince, MD
Izmir Bozyaka Education and Resarch Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2022
First Posted
July 13, 2022
Study Start
July 15, 2022
Primary Completion
March 1, 2024
Study Completion
April 1, 2024
Last Updated
September 5, 2023
Record last verified: 2023-01